共 89 条
[1]
Chun YS(2010)Defining venous involvement in borderline resectable pancreatic cancer Ann Surg Oncol. 17 2832-2838
[2]
Milestone BN(2008)Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol. 26 3496-3502
[3]
Watson JC(2008)Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head J Clin Oncol. 26 3487-3495
[4]
Evans DB(1992)Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg. 127 1335-1339
[5]
Varadhachary GR(2005)Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome J Clin Oncol. 23 1237-1244
[6]
Crane CH(1999)Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy J Clin Oncol. 17 460-469
[7]
Varadhachary GR(2006)A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography Ann Surg Oncol. 13 1047-1053
[8]
Wolff RA(2001)Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration Ann Surg Oncol. 8 123-132
[9]
Crane CH(2005)Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer Ann Surg Oncol. 12 214-221
[10]
Evans DB(2008)Borderline resectable pancreatic cancer: the importance of this emerging stage of disease J Am Coll Surg. 206 833-846